home / stock / dh / dh news


DH News and Press, Definitive Healthcare Corp. From 02/28/23

Stock Information

Company Name: Definitive Healthcare Corp.
Stock Symbol: DH
Market: NASDAQ
Website: definitivehc.com

Menu

DH DH Quote DH Short DH News DH Articles DH Message Board
Get DH Alerts

News, Short Squeeze, Breakout and More Instantly...

DH - Definitive Healthcare to Present at the Raymond James 2023 Institutional Investors Conference

FRAMINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Raymond James 2023 Ins...

DH - AMWL and CFRX among healthcare movers

Gainers: Lucira Health ( LHDX ) +357% . ContraFect ( CFRX ) +75% . Moolec Science ( MLEC ) +29% . Werewolf  ( HOWL ) +14% . The Pennant Group ( PNTG ) +16% . Losers: Genprex ( GNPX ) -17% . ETAO Internationl ( ET...

DH - Definitive Healthcare Corp. (DH) Q4 2022 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q4 2022 Earnings Conference Call February 23, 2023 05:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chairman Rick Booth - CFO Conference Call Participants David Gro...

DH - Definitive Healthcare GAAP EPS of $0.07 beats by $0.17, revenue of $60.6M beats by $2.15M

Definitive Healthcare press release ( NASDAQ: DH ): Q4 GAAP EPS of $0.07 beats by $0.17 . Revenue of $60.6M (+30.9% Y/Y) beats by $2.15M . Sees Q1 2023 revenue to be in the range of $56.5–$58.5 million. The consensus estimate is $59.53M. Q1 2023 adj. EPS...

DH - Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022

Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million FRAMINGHAM, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an in...

DH - Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2022 financial results will be ...

DH - Definitive Healthcare introduces the Atlas Dataset

FRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today introduced its Atlas Dataset, which provides the foundation for the company’s healthcare commercial intelligence and powers Defi...

DH - Definitive Healthcare greatly expands all-payor medical and prescription claims coverage

FRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced expanded coverage of its prescription and all-payor medical claims data in the Atlas Dataset . The company’s Atlas...

DH - Definitive Healthcare: A High Growth Company On Sale

Summary Definitive Healthcare is now down almost 80% from its all-time high in 2021. The healthcare technology company has attractive products and operates in a large and growing market. It reported impressive growth alongside strong profitability, despite facing macro headwinds. ...

DH - Definitive Healthcare to Present at the 25th Annual Needham Growth Conference

FRAMINGHAM, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Robert Musslewhite, and its Chief Financial Officer, R...

Previous 10 Next 10